Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study
Contributeurs/tricesLeidi, Antonio Siro Gabriele ; Koegler, Flora Anaïd; Dumont, Roxane; Dubos, Richard; Zaballa, María-Eugenia; Piumatti, Giovanni; Coen, Matteo ; Berner, Amandine; Darbellay, Pauline; Vetter, Pauline; Vuilleumier, Nicolas; Kaiser, Laurent; Courvoisier, Delphine; Azman, Andrew; Guessous, Idris; Stringhini, Silvia; SEROCoV-POP study group
Publié dansClinical Infectious Diseases
Date de publication2021
Résumé
Mots-clés
- SARS-CoV-2
- Reinfection
- COVID-19
- Antibody
- Protection
Citation (format ISO)
LEIDI, Antonio Siro Gabriele et al. Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study. In: Clinical Infectious Diseases, 2021. doi: 10.1093/cid/ciab495
Fichiers principaux (2)
Article (Accepted version)
Article (Published version)
Fichiers secondaires (1)
Identifiants
- PID : unige:157201
- DOI : 10.1093/cid/ciab495
- PMID : 34043763
URL commercialhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241483/
ISSN du journal1058-4838